down arrow

Jubilant Pharmo

Part of MojoOne Strategy
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
898.15
68.15 (8.21%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.33 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

835.90901.70

52 Week

607.501,309.00
Valuation
Technical
Day's Volume

CASH

4.33 lacs (30.18%) Volume

Shareholding (Dec 2024)

FII

16.96%

Held by 149 FIIs

DII

6.98%

Held by 10 DIIs

Promoter

50.68%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of -3.22% and Operating profit at -10.65% over the last 5 years

 
2

With a growth in Net Profit of 89.49%, the company declared Very Positive results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

With ROCE of 8.2, it has a Very Attractive valuation with a 1.9 Enterprise value to Capital Employed

5

High Institutional Holdings at 23.94%

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 14,306 Cr (Mid Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.60%

stock-summary
Debt Equity

0.34

stock-summary
Return on Equity

6.57%

stock-summary
Price to Book

2.23

Revenue and Profits (1 Year):
Net Sales:
1,822 Cr
(Quarterly Results - Dec 2024)
Net Profit:
101 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.6%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-21.64%
0%
-21.64%
1 Year
38.38%
0.74%
39.12%
2 Years
195.98%
3.21%
199.19%
3 Years
90.37%
3.77%
94.14%
4 Years
21.96%
2.41%
24.37%
5 Years
163.77%
4.38%
168.15%

Latest dividend: 5 per share ex-dividend date: Aug-02-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-3.22%
EBIT Growth (5y)
-10.65%
EBIT to Interest (avg)
3.62
Debt to EBITDA (avg)
3.20
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.76
Tax Ratio
13.55%
Dividend Payout Ratio
102.46%
Pledged Shares
0
Institutional Holding
23.94%
ROCE (avg)
10.04%
ROE (avg)
7.91%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
33
Price to Book Value
2.23
EV to EBIT
20.99
EV to EBITDA
13.84
EV to Capital Employed
1.92
EV to Sales
2.15
PEG Ratio
0.03
Dividend Yield
0.60%
ROCE (Latest)
8.22%
ROE (Latest)
6.57%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 17 Schemes (3.64%)

FIIs

Held by 149 FIIs (16.96%)

Promoter with highest holding

Spb Trustee Company Pvt Ltd (20.52%)

Highest Public shareholder

East Bridge Capital Master Fund I Ltd (3.92%)

Individual Investors Holdings

18.09%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 8.62% vs 8.03% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 51.05% vs 526.29% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,821.70",
          "val2": "1,677.10",
          "chgp": "8.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "287.40",
          "val2": "218.00",
          "chgp": "31.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "55.60",
          "val2": "71.30",
          "chgp": "-22.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-18.90",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "100.90",
          "val2": "66.80",
          "chgp": "51.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.85%",
          "val2": "13.09%",
          "chgp": "2.76%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 6.64% vs 7.08% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 748.91% vs 31.16% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,484.00",
          "val2": "3,267.20",
          "chgp": "6.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "540.90",
          "val2": "411.40",
          "chgp": "31.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "132.00",
          "val2": "128.00",
          "chgp": "3.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "381.70",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "584.90",
          "val2": "68.90",
          "chgp": "748.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.62%",
          "val2": "12.72%",
          "chgp": "2.90%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 7.31% vs 7.40% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 405.38% vs 268.15% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,305.70",
          "val2": "4,944.30",
          "chgp": "7.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "828.30",
          "val2": "629.40",
          "chgp": "31.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "187.60",
          "val2": "199.30",
          "chgp": "-5.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "362.80",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "685.80",
          "val2": "135.70",
          "chgp": "405.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.61%",
          "val2": "12.73%",
          "chgp": "2.88%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.70% vs 2.47% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 226.43% vs -114.73% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,702.90",
          "val2": "6,281.73",
          "chgp": "6.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "900.80",
          "val2": "776.25",
          "chgp": "16.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "272.30",
          "val2": "188.20",
          "chgp": "44.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-168.90",
          "val2": "-56.82",
          "chgp": "-197.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "77.10",
          "val2": "-60.98",
          "chgp": "226.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.56%",
          "val2": "12.48%",
          "chgp": "1.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,821.70
1,677.10
8.62%
Operating Profit (PBDIT) excl Other Income
287.40
218.00
31.83%
Interest
55.60
71.30
-22.02%
Exceptional Items
-18.90
0.00
Consolidate Net Profit
100.90
66.80
51.05%
Operating Profit Margin (Excl OI)
15.85%
13.09%
2.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 8.62% vs 8.03% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2024 is 51.05% vs 526.29% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
3,484.00
3,267.20
6.64%
Operating Profit (PBDIT) excl Other Income
540.90
411.40
31.48%
Interest
132.00
128.00
3.12%
Exceptional Items
381.70
0.00
Consolidate Net Profit
584.90
68.90
748.91%
Operating Profit Margin (Excl OI)
15.62%
12.72%
2.90%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 6.64% vs 7.08% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 748.91% vs 31.16% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
5,305.70
4,944.30
7.31%
Operating Profit (PBDIT) excl Other Income
828.30
629.40
31.60%
Interest
187.60
199.30
-5.87%
Exceptional Items
362.80
0.00
Consolidate Net Profit
685.80
135.70
405.38%
Operating Profit Margin (Excl OI)
15.61%
12.73%
2.88%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 7.31% vs 7.40% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 405.38% vs 268.15% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
6,702.90
6,281.73
6.70%
Operating Profit (PBDIT) excl Other Income
900.80
776.25
16.05%
Interest
272.30
188.20
44.69%
Exceptional Items
-168.90
-56.82
-197.25%
Consolidate Net Profit
77.10
-60.98
226.43%
Operating Profit Margin (Excl OI)
13.56%
12.48%
1.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 6.70% vs 2.47% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 226.43% vs -114.73% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Jubilant Pharmova Ltd stock-summary
stock-summary
Jubilant Pharmova Ltd
Mid Cap
Pharmaceuticals & Drugs
Jubilant Pharmova Limited, (Formerly known as Jubilant Life Sciences Limited), is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions. The Company is engaged in pharmaceuticals, contract research and development services and proprietary novel drugs.
Company Coordinates stock-summary
Company Details
Bhartiagram Gajraula , Amroha Uttar Pradesh : 244223
stock-summary
Tel: 91-5924-267200
stock-summary
http://www.jubilantpharmova.com
stock-summary
investors@jubl.com/support@jubl.com
Registrar Details
Alankit Assignments Ltd , 205-208 , Anarkali Complex, Jhandewala Extension, New Delhi
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."